Monday, August 31, 2026

2:30 PM - 4:00 PM

---

Details

Organised by the FIP Community Pharmacy Section in collaboration with the FIP Academic Pharmacy Section, the FIP Regulatory Advisory Group and the FIP Technology Advisory Group Chair(s) Ms Clara Mayunga, Steering Committee Member, the FIP Early Career Pharmaceutical Group, The Netherlands & Dr Virginia Olmos, Vice President, International Pharmaceutical Federation, Uruguay Introduction: Health inequities remain a major challenge across healthcare systems, disproportionately affecting underserved and marginalised populations. Pharmacists, as highly accessible healthcare professionals, are uniquely positioned to help close these gaps by improving access, promoting prevention, and optimising therapeutic outcomes. This session explores the growing evidence — including landmark Canadian research — demonstrating pharmacists’ impact on public health and equity. Through presentations, case examples, and interactive discussion, the session will highlight: • Practical strategies for community and primary-care pharmacy • Innovative, collaborative models of care across disciplines and sectors • The role of education, policy, regulation, and FIP structures in enabling pharmacists as proactive agents of change Programme: Learning objectives: 1. Describe key evidence from Canadian pharmacy practice research (including Tsuyuki’s work) relevant to improving access, outcomes and equity. 2. Identify specific barriers and facilitators for pharmacists in addressing health-equity gaps (e.g., among underserved populations). 3. Explore practical strategies and roles for pharmacists and pharmacy teams to advance health equity in community and primary-care settings. 4. Recognise how FIP programmes, policy work, education, and collaboration can support equity-focused pharmacy practice. Take home messages: Pharmacists are vital agents for advancing health equity. Evidence shows their interventions improve access, outcomes, and cost-effectiveness, especially for underserved populations. By embracing expanded roles, cultural competence, collaboration, and supportive policies, pharmacists can reduce inequities, strengthen primary care, and ensure every community benefits from equitable, patient-centred pharmacy services. By emphasising interprofessional collaboration, global case examples, and FIP-enabled support mechanisms, the session aligns with the congress theme “One Health, One Pharmacy – Bridging Practice, Education, and Science” and complements related submissions, including the ECPG-led session on pharmacy-led equity solutions. FIP Development Goals: To learn more about these FIP Development Goals, click on the links below. FIP Development Goal 10: Equity and Equality FIP Development Goal 11: Impact and Outcomes FIP Development Goal 15: People-Centred Care

---

Chairs & speakers